Diagnosing Cancer with a Blood Test - Sir Harpal Kumar | WIRED Health

Grail’s Galleri blood test targets 50 types of cancer and aims to screen for many more types of tumor than was previously possible. Large-scale clinical trials are underway.
In this session, Sir Harpal Kumar, president, BioPharma business and europe,
GRAIL shares how GRAIL is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test.
The next step is the NHS-Galleri clinical trial-to demonstrate that the test works at scale “We will get first data from this trial next year, then if that data looks good, they will extend the pilot to a million people over the next few years, then complete it in the next three years,” says Kumar at WIRED Health 2023.
ABOUT WIRED
WIRED brings you the future as it happens - the people, the trends, the big ideas that will change our lives. An award-winning printed monthly and online publication. WIRED is an agenda-setting magazine offering brain food on a wide range of topics, from science, technology and business to pop-culture and politics.
CONNECT WITH WIRED
Events: wired.uk/events
Subscribe for Events Information: bit.ly/3K0Un0f
Web: bit.ly/VideoWired
Twitter: bit.ly/TwitterWired
Facebook: bit.ly/FacebookWired
Instagram: bit.ly/InstagramWired
Magazine: bit.ly/MagazineWired
Newsletter: bit.ly/3K0Un0f